4-(3',4'-Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one oxime

BGC Id:	734754913456
CAS No:	152642-35-8
Synonyms:	1(2H)-Naphthalenone, 4-(3,4-dichlorophenyl)-3,4-dihydro-, oxime
Molecular Formula:	C16H13Cl2NO
Molecular Weight:	306.19
EINECS:

Verified providers in 2025

The following notable provider has been checked and can be recommended.

Leap Chem Co., Ltd

会社のタイプ: Bulk and laboratory supplier

電話: +852-30606658
カントリー: P.R.China

LEAPChem, a specialized fine chemicals supplier for research, development and production. LEAPChem provides nearly 50,000 rare and innovative chemical products to support the evolving needs of our customers in research & bulk manufacturing activities. As a highly customer-oriented enterprise, we are committed to providing high-quality customer se ...

INQUIRY | ORDER

What other providers are available for CAS 152642-35-8?

The last intensive check and update was carried out on 2025/09/27.

Identify

Synonyms:

1(2H)-Naphthalenone, 4-(3,4-dichlorophenyl)-3,4-dihydro-, oxime

CAS:

152642-35-8

EINECS:

Molecular Formula:

C16H13Cl2NO

MDL:

SMILES:

CCCCCC(=O)OCC

Properties

Molecular Weight:

306.19 g·mol−1

Melting point:

163°C (lit.)

Solubility:

Soluble in Chloroform and Dichloromethane

The following providers cannot be verified precisely. The companies have offered the product in the past, but despite all care, the companies could not confirm it 100 percent!

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc. now offers over 140,000 specialty biochemicals under our ChemCruz™ brand. Santa Cruz Biotechnology, Inc. is focused... Request

What other providers are available for CAS 152642-35-8?

In addition to the providers presented here for 4-(3',4'-Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one oxime with the CAS number 152642-35-8, there are other 5 providers with slightly different product names available for this CAS number.

Sertraline Oxime Impurity

+1 additional providers that we know from the past

(2S,4R)-Methyl 4-hydroxypyrrolidine-2-carboxylate

+4 additional providers that we know from the past